We are live on ! Find out more
FCMV

Foresite Capital Management V Portfolio holdings

AUM $271M
1-Year Est. Return 309.87%
This Fund
S&P 500
This Quarter Est. Return
+42.97%
1 Year Est. Return
+309.87%
3 Year Est. Return
+356.88%
5 Year Est. Return
+250.56%
10 Year Est. Return
–
AUM
$107M
AUM Growth
+$33.1M
Cap. Flow
+$5.93M
Cap. Flow %
5.57%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
CGON icon
CG Oncology
CGON
+$28.3M

Top Sells

Rank Stock Value
1
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
+$16.6M
2
HIMS icon
Hims & Hers Health
HIMS
+$5.71M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIMS icon
1
Hims & Hers Health
HIMS
$6.26B
$51.5M 48.31%
3,326,783
-506,598
-13% -$5.71M
CGON icon
2
CG Oncology
CGON
$6.44B
$30.4M 28.54%
+692,550
New +$28.3M
IRON icon
3
Disc Medicine
IRON
$3.03B
$15.2M 14.23%
243,513
– –
KNTE
4
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$9.38M 8.8%
3,525,957
– –
ME
5
DELISTED
23andMe Holding Co
ME
$124K 0.12%
11,610
– –
THRX
6
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
– –
-4,108,796
Closed -$16.6M

Similar funds

MAM
Mullooly Asset Management Wall Township, New Jersey $271M AUM 16.93% 1-Year Est. Return
MLM
Mount Lucas Management Newtown, Pennsylvania $271M AUM 25.49% 1-Year Est. Return
MCM
Moerus Capital Management New York $271M AUM 58.78% 1-Year Est. Return
RP
Ravenswood Partners Mclean, Virginia $271M AUM
PCM
Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return
S
Siemens Munich, Germany $272M AUM 183.71% 1-Year Est. Return
VW
Veridan Wealth West Linn, Oregon $270M AUM
TP
TritonPoint Partners Chevy Chase, Maryland $272M AUM

Foresite Capital Management V's Q1 2024 Portfolio in Review

As of Q1 2024, Foresite Capital Management V held 6 positions worth $107M, up 45% from $73.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Foresite Capital Management V deployed $5.93M of net new capital in Q1 2024, opening 1 new position. Its largest new stake was CG Oncology: 692,550 shares worth $30.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Hims & Hers Health, an estimated $5.71M trimmed.

  • Foresite Capital Management V's largest Q1 2024 buy was CG Oncology: 692,550 shares worth $30.4M.
  • Foresite Capital Management V's biggest Q1 2024 reduction was Hims & Hers Health, cutting an estimated $5.71M.
  • Foresite Capital Management V fully exited Theseus Pharmaceuticals, Inc. Common Stock in Q1 2024, selling an estimated $16.6M.
  • Foresite Capital Management V's ten largest holdings make up 100% of its $107M portfolio in Q1 2024.
  • Foresite Capital Management V opened 1 new position and closed 1 in Q1 2024.
  • Foresite Capital Management V's portfolio value rose 45% quarter-over-quarter to $107M.

Based on Foresite Capital Management V's 13F filing for Q1 2024, filed 15 May 2024.